Cardioprotective effect of dipeptidyl peptidase-4 inhibitor during ischemia-reperfusion injury
Background: Dipeptidyl peptidase-4 (DPP-4) inhibitor is a new anti-diabetic drug for type-2 diabetes mellitus patients. Despite its benefits on glycemic control, the effects of DPP-4 inhibitor on the heart during ischemia-reperfusion (I/R) periods are not known. We investigated the effect of DPP-4 i...
Saved in:
Main Authors: | Kroekkiat Chinda, Siripong Palee, Sirirat Surinkaew, Mattabhorn Phornphutkul, Siriporn Chattipakorn, Nipon Chattipakorn |
---|---|
Format: | Journal |
Published: |
2018
|
Subjects: | |
Online Access: | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84879120827&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/52838 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Chiang Mai University |
Similar Items
-
Cardioprotective effect of dipeptidyl peptidase-4 inhibitor during ischemia-reperfusion injury
by: Kroekkiat Chinda, et al.
Published: (2018) -
Cardioprotective effect of dipeptidyl peptidase-4 inhibitor during ischemia-reperfusion injury
by: Chinda K., et al.
Published: (2014) -
Cardioprotective effect of dipeptidyl peptidase-4 inhibitor during ischemia-reperfusion injury
by: Chinda K., et al.
Published: (2014) -
Combined vildagliptin and metformin exert better cardioprotection than monotherapy against ischemia-reperfusion injury in obese-insulin resistant rats
by: Nattayaporn Apaijai, et al.
Published: (2018) -
Combined vildagliptin and metformin exert better cardioprotection than monotherapy against ischemia-reperfusion injury in obese-insulin resistant rats
by: Nattayaporn Apaijai, et al.
Published: (2018)